UBISOFT ENTERTAINMENT (UBI.PA)

FR0000054470 - Common Stock

12.345  -0.29 (-2.33%)

Fundamental Rating

5

Taking everything into account, UBI scores 5 out of 10 in our fundamental rating. UBI was compared to 48 industry peers in the Entertainment industry. Both the profitability and the financial health of UBI get a neutral evaluation. Nothing too spectacular is happening here. UBI has a correct valuation and a medium growth rate.



5

1. Profitability

1.1 Basic Checks

UBI had positive earnings in the past year.
In the past year UBI had a positive cash flow from operations.
In multiple years UBI reported negative net income over the last 5 years.
UBI had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of UBI (-1.18%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -3.22%, UBI is in line with its industry, outperforming 45.45% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.81%, UBI is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -1.18%
ROE -3.22%
ROIC 0.81%
ROA(3y)-1.97%
ROA(5y)-1.46%
ROE(3y)-6.88%
ROE(5y)-4.79%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

UBI's Profit Margin has improved in the last couple of years.
UBI has a Operating Margin of 2.46%. This is comparable to the rest of the industry: UBI outperforms 47.73% of its industry peers.
In the last couple of years the Operating Margin of UBI has grown nicely.
UBI has a better Gross Margin (90.35%) than 77.27% of its industry peers.
In the last couple of years the Gross Margin of UBI has grown nicely.
Industry RankSector Rank
OM 2.46%
PM (TTM) N/A
GM 90.35%
OM growth 3Y-8.08%
OM growth 5Y4.36%
PM growth 3Y13.94%
PM growth 5Y4.83%
GM growth 3Y2.2%
GM growth 5Y2.09%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so UBI is destroying value.
The number of shares outstanding for UBI has been increased compared to 1 year ago.
The number of shares outstanding for UBI has been increased compared to 5 years ago.
Compared to 1 year ago, UBI has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.36, we must say that UBI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.36, UBI perfoms like the industry average, outperforming 56.82% of the companies in the same industry.
The Debt to FCF ratio of UBI is 4.55, which is a neutral value as it means it would take UBI, 4.55 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of UBI (4.55) is better than 68.18% of its industry peers.
A Debt/Equity ratio of 1.32 is on the high side and indicates that UBI has dependencies on debt financing.
With a Debt to Equity ratio value of 1.32, UBI is not doing good in the industry: 65.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 4.55
Altman-Z 1.36
ROIC/WACC0.17
WACC4.92%

2.3 Liquidity

UBI has a Current Ratio of 2.32. This indicates that UBI is financially healthy and has no problem in meeting its short term obligations.
UBI's Current ratio of 2.32 is amongst the best of the industry. UBI outperforms 90.91% of its industry peers.
UBI has a Quick Ratio of 2.29. This indicates that UBI is financially healthy and has no problem in meeting its short term obligations.
UBI's Quick ratio of 2.29 is amongst the best of the industry. UBI outperforms 93.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 2.29

5

3. Growth

3.1 Past

UBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.93%, which is quite impressive.
UBI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.43% yearly.
The Revenue has grown by 11.34% in the past year. This is quite good.
Measured over the past years, UBI shows a small growth in Revenue. The Revenue has been growing by 4.51% on average per year.
EPS 1Y (TTM)105.93%
EPS 3Y-10.3%
EPS 5Y-8.43%
EPS Q2Q%-16500%
Revenue 1Y (TTM)11.34%
Revenue growth 3Y1.14%
Revenue growth 5Y4.51%
Sales Q2Q%-21.9%

3.2 Future

UBI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.05% yearly.
The Revenue is expected to grow by 4.59% on average over the next years.
EPS Next Y-103.48%
EPS Next 2Y-21.93%
EPS Next 3Y-4.04%
EPS Next 5Y4.05%
Revenue Next Year-8.43%
Revenue Next 2Y1.11%
Revenue Next 3Y1.5%
Revenue Next 5Y4.59%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 88.18, the valuation of UBI can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of UBI is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.54, UBI is valued quite expensively.
A Price/Forward Earnings ratio of 11.32 indicates a reasonable valuation of UBI.
75.00% of the companies in the same industry are more expensive than UBI, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.99. UBI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 88.18
Fwd PE 11.32

4.2 Price Multiples

79.55% of the companies in the same industry are more expensive than UBI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, UBI is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.14
EV/EBITDA 3.26

4.3 Compensation for Growth

A cheap valuation may be justified as UBI's earnings are expected to decrease with -4.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.93%
EPS Next 3Y-4.04%

0

5. Dividend

5.1 Amount

UBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UBISOFT ENTERTAINMENT

EPA:UBI (12/24/2024, 7:00:00 PM)

12.345

-0.29 (-2.33%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners43.6%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.61B
Analysts67.41
Price Target17.88 (44.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.09%
PT rev (3m)-40.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-104.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.98%
Valuation
Industry RankSector Rank
PE 88.18
Fwd PE 11.32
P/S 0.76
P/FCF 3.14
P/OCF 2.57
P/B 0.95
P/tB N/A
EV/EBITDA 3.26
EPS(TTM)0.14
EY1.13%
EPS(NY)1.09
Fwd EY8.84%
FCF(TTM)3.93
FCFY31.84%
OCF(TTM)4.8
OCFY38.87%
SpS16.34
BVpS12.98
TBVpS-4.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.18%
ROE -3.22%
ROCE 1.34%
ROIC 0.81%
ROICexc 1.06%
ROICexgc 3.87%
OM 2.46%
PM (TTM) N/A
GM 90.35%
FCFM 24.05%
ROA(3y)-1.97%
ROA(5y)-1.46%
ROE(3y)-6.88%
ROE(5y)-4.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-33.29%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.78%
ROICexc growth 5Y-10.93%
OM growth 3Y-8.08%
OM growth 5Y4.36%
PM growth 3Y13.94%
PM growth 5Y4.83%
GM growth 3Y2.2%
GM growth 5Y2.09%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 4.55
Debt/EBITDA 2.5
Cap/Depr 13.39%
Cap/Sales 5.31%
Interest Coverage 250
Cash Conversion 69.7%
Profit Quality N/A
Current Ratio 2.32
Quick Ratio 2.29
Altman-Z 1.36
F-Score6
WACC4.92%
ROIC/WACC0.17
Cap/Depr(3y)11.34%
Cap/Depr(5y)13.13%
Cap/Sales(3y)4.42%
Cap/Sales(5y)4.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.93%
EPS 3Y-10.3%
EPS 5Y-8.43%
EPS Q2Q%-16500%
EPS Next Y-103.48%
EPS Next 2Y-21.93%
EPS Next 3Y-4.04%
EPS Next 5Y4.05%
Revenue 1Y (TTM)11.34%
Revenue growth 3Y1.14%
Revenue growth 5Y4.51%
Sales Q2Q%-21.9%
Revenue Next Year-8.43%
Revenue Next 2Y1.11%
Revenue Next 3Y1.5%
Revenue Next 5Y4.59%
EBIT growth 1Y116.85%
EBIT growth 3Y-7.03%
EBIT growth 5Y9.06%
EBIT Next Year117.63%
EBIT Next 3Y42.52%
EBIT Next 5Y26.23%
FCF growth 1Y-45.29%
FCF growth 3Y-21.2%
FCF growth 5Y-14.04%
OCF growth 1Y-38.92%
OCF growth 3Y-17.51%
OCF growth 5Y-11.18%